Literature DB >> 15291907

A protocol for oral desensitization in children with IgE-mediated cow's milk allergy.

P Meglio1, E Bartone, M Plantamura, E Arabito, P G Giampietro.   

Abstract

OBJECTIVES: To desensitize children with severe immunoglobulin (Ig)E-mediated cow's milk allergy in a period of 6 months by introducing increasing daily doses of cow's milk (CM) in order to enable the child to assume 200 ml of CM daily, or to induce tolerance of the highest possible CM dose. STUDY
DESIGN: Twenty-one children at least 6 years old with severe IgE-mediated CM allergy were admitted to the study. A convincing history of IgE-mediated CM allergy or a positive double-blind placebo-controlled food challenge with CM confirmed the diagnosis. Oral desensitization was performed with increasing doses starting from 0.06 mg of CM proteins.
RESULTS: Overall, 15 of 21 children (71.4%) achieved the daily intake of 200 ml during a 6-month period; three of 21 children (14.3%) tolerated 40-80 ml/day of undiluted CM; three of 21 children (14.3%) failed the desensitization because they presented allergic symptoms after ingesting minimal amounts of diluted CM.
CONCLUSIONS: We successfully desensitized 15 of 21 children with severe IgE-mediated CM allergy in a period of 6 months. We stress the importance of the partial outcome in those three of 21 children who could not reach the maximum amount of 200 ml/day of whole CM, but were able to tolerate 40-80 ml/day of CM. In this way we dramatically reduced the risk of severe reactions after accidental or unnoticed introduction of low quantities of CM. We do not propose generalizing this method beyond trained staff.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15291907     DOI: 10.1111/j.1398-9995.2004.00542.x

Source DB:  PubMed          Journal:  Allergy        ISSN: 0105-4538            Impact factor:   13.146


  74 in total

Review 1.  Future therapies for food allergies.

Authors:  Anna Nowak-Węgrzyn; Hugh A Sampson
Journal:  J Allergy Clin Immunol       Date:  2011-01-31       Impact factor: 10.793

2.  Who should manage infants and young children with food induced symptoms?

Authors:  B Niggemann; R G Heine
Journal:  Arch Dis Child       Date:  2006-05       Impact factor: 3.791

Review 3.  The future of food allergy therapeutics.

Authors:  Michele Henson; A Wesley Burks
Journal:  Semin Immunopathol       Date:  2012-06-27       Impact factor: 9.623

Review 4.  Does early feeding promote development of oral tolerance?

Authors:  Debra J Palmer; Susan L Prescott
Journal:  Curr Allergy Asthma Rep       Date:  2012-08       Impact factor: 4.806

Review 5.  New perspectives for use of native and engineered recombinant food proteins in treatment of food allergy.

Authors:  Anna Nowak-Wegrzyn
Journal:  Immunol Allergy Clin North Am       Date:  2007-02       Impact factor: 3.479

Review 6.  Oral and Sublingual Immunotherapy for Treatment of IgE-Mediated Food Allergy.

Authors:  Amy M Scurlock
Journal:  Clin Rev Allergy Immunol       Date:  2018-10       Impact factor: 8.667

7.  A pilot study of omalizumab to facilitate rapid oral desensitization in high-risk peanut-allergic patients.

Authors:  Lynda C Schneider; Rima Rachid; Jennifer LeBovidge; Emily Blood; Mudita Mittal; Dale T Umetsu
Journal:  J Allergy Clin Immunol       Date:  2013-10-28       Impact factor: 10.793

Review 8.  Will we be able to desensitize food allergies by either injection or oral immunotherapy?

Authors:  Rafael Firszt; A Wesley Burks
Journal:  Curr Allergy Asthma Rep       Date:  2011-08       Impact factor: 4.806

9.  A randomized, double-blind, placebo-controlled study of milk oral immunotherapy for cow's milk allergy.

Authors:  Justin M Skripak; Scott D Nash; Hannah Rowley; Nga H Brereton; Susan Oh; Robert G Hamilton; Elizabeth C Matsui; A Wesley Burks; Robert A Wood
Journal:  J Allergy Clin Immunol       Date:  2008-10-25       Impact factor: 10.793

10.  Oral desensitization to milk: how to choose the starting dose!

Authors:  Francesca Mori; Neri Pucci; Maria Elisabetta Rossi; Maurizio de Martino; Chiara Azzari; Elio Novembre
Journal:  Pediatr Allergy Immunol       Date:  2009-07-13       Impact factor: 6.377

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.